Smarter Team

About the Author Smarter Team

Smarter Analyst was established to fill a gap in financial reporting for sell-side investors, where they can read exclusive reports in real time. Smarter Analyst provides coverage of equities research, unique analyst insights, and outstanding articles from knowledgeable contributors, in addition to the latest stock market news, all hand-picked by our editors.

After Teva Pharmaceutical’s Big Jump, This Analyst Remains Unenthused

Cost cutting is great, but the benefits have been quickly priced into the stock.

If Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Looks Cheap, It May Be Cheap for a Reason

Should you pull the trigger on Teva? Guggenheim’s Rohit Vanjani is fine staying sidelined.

Trading Cable Heading into the New Year

The GBP/USD currency pair is holding at the critical 1.34 level.

Veeva Systems Is Worth the Buy Longer-Term, Says Canaccord

While Veeva Systems (NYSE:VEEV) shares are dipping close to 7% after a print that failed to impress the Street, Canaccord’s┬áRichard Davis highlights enticing …

This Analyst Finds Nutanix Well-Positioned in the Enterprise Market Following Raymond James Tech Conference

After Nutanix Inc (NASDAQ:NTNX) CFO Duston Williams discussed the company’s transition to software taking center stage for the business at the annual Raymond …

Does Helios and Matheson Analytics’ Selloff Represents a Buying Opportunity?

Helios and Matheson Analytics (NASDAQ:HMNY) is an IT consulting company — but one with a twist. Helios, you see, owns a majority stake …

Does This Analyst Make a Good Case for Matheson Analytics Inc (HMNY)?

For much of its lifetime as a public company, the stock chart of IT consulting solutions firm Helios and Matheson Analytics Inc (NASDAQ:HMNY) …

Guggenheim Storms Into the Dermatology Space; Initiates Buy on Revance Therapeutics, Inc. (RVNC)

Guggenheim analyst Rohit Vanjani has initiated coverage of the dermatology space, announcing ratings on four pharmaceuticals stocks. We don’t have time to cover …

Raymond James Sings the Praises of Adamis Pharmaceuticals; Here’s Why

What does the future hold for Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)? Raymond James analyst Elliot Wilbur is out today with a bullish note on …

Investing Guru Jim Simons Rolls Out the Red Carpet for Valeant Pharmaceuticals, Cuts Opko Health

Jim Simons, the founder of one of the world’s most successful hedge funds, is splashing out on controversial healthcare stock Valeant Pharmaceuticals (NYSE:VRX). …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts